Cited by 206Salmonella and Campylobacter epidemiologyGlycosylation and Glycoproteins ResearchEscherichia coli research studies

The Mucin Muc2 Limits Pathogen Burdens and Epithelial Barrier Dysfunction during Salmonella enterica Serovar Typhimurium Colitis

Open access
Zarepour, Maryam, Bhullar, Kirandeep, Montero, Marinieve, Ma, Caixia, Huang, Tina, Velcich, Anna, Xia, Lijun, Vallance, Bruce A.·2013·Infection and Immunity

Abstract

Salmonella enterica serovar Typhimurium is a model organism used to explore the virulence strategies underlying Salmonella pathogenesis. Although intestinal mucus is the first line of defense in the intestine, its role in protection against Salmonella is still unclear. The intestinal mucus layer is composed primarily of the Muc2 mucin, a heavily O-glycosylated glycoprotein. The core 3-derived O-glycans of Muc2 are synthesized by core 3 β1,3- N -acetylglucosaminyltransferase (C3GnT). Mice lacking these glycans still produce Muc2 but display a thinner intestinal mucus barrier. We began our investigations by comparing Salmonella -induced colitis and mucus dynamics in Muc2 -deficient ( Muc2 −/− ) mice, C3GnT −/− mice, and wild-type C57BL/6 (WT) mice. Salmonella infection led to increases in luminal Muc2 secretion in WT and C3GnT −/− mice. When Muc2 −/− mice were infected with Salmonella , they showed dramatic susceptibility to infection, carrying significantly higher cecal and liver pathogen burdens, and developing significantly higher barrier disruption and higher mortality rates, than WT mice. We found that the exaggerated barrier disruption in infected Muc2 −/− mice was invA dependent. We also tested the susceptibility of C3GnT −/− mice and found that they carried pathogen burdens similar to those of WT mice but developed exaggerated barrier disruption. Moreover, we found that Muc2 −/− mice were impaired in intestinal alkaline phosphatase (IAP) expression and lipopolysaccharide (LPS) detoxification activity in their ceca, potentially explaining their high mortality rates during infection. Our data suggest that the intestinal mucus layer (Muc2) and core 3 O-glycosylation play critical roles in controlling Salmonella intestinal burdens and intestinal epithelial barrier function, respectively.

Integrity signals

Registry

Crossref · 10.1128/iai.00854-13

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pathogenic bacteria can be expected to have capacities to destroy mucus because they have developed specific mechanisms to circumvent the mucus protective system.

    “Such capacities can be expected among pathogenic bacteria as these have developed specific mechanisms to circumvent the mucus protective system 36, 37, 38.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zarepour, M., Bhullar, K., Montero, M., Ma, C., Huang, T., Velcich, A., Xia, L., & Vallance, B. A.
Affiliations
  • Child and Family Research Institute (CA)
  • Albert Einstein College of Medicine (US)
  • Oklahoma Medical Research Foundation (US)
Venue
Infection and Immunity
Published
2013-10
Volume
81
Issue
10
Pages
3672-3683
ISSN
  • 0019-9567 (ISSN-L)
  • 1098-5522
OpenAlex
W2106362526
Cited by
206
References
53
Citations by year
2026: 4 · 2025: 15 · 2024: 15 · 2023: 21 · 2022: 21 · 2021: 20 · 2020: 21 · 2019: 25 · 2018: 12 · 2017: 14 · 2016: 6 · 2015: 21 · 2014: 10
FWCI
18.24
Type
journal article
Language
en
Open access
Locations
  • Infection and Immunity (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Canadian Institutes of Health Research
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK085691)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Escherichia coli research studies
Keywords
MUC2, Salmonella typhimurium, intestinal mucus barrier, invA gene, intestinal alkaline phosphatase, lipopolysaccharide detoxification, epithelial barrier dysfunction, pathogen burden, host susceptibility to infection
MeSH terms
Animals, Colitis, Gene Expression Regulation, Intestinal Mucosa, Lipopolysaccharides, Mice, Inbred C57BL, Polysaccharides, Salmonella Infections, Animal, Salmonella typhimurium, Mice, Knockout, Mice, Mucin-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review